RPGRIP1-Like (RPGRIP1L) Peptide
RPGRIP1L
Reactivité: Humain
Hôte: Synthetic
BP, BI
-
- Antigène Tous les produits RPGRIP1L
- RPGRIP1L (RPGRIP1-Like (RPGRIP1L))
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Attributs du produit
- RPGRIP1L peptide corresponds to 13 amino acids of RPGRIP1L.
-
RPGRIP1-Like (RPGRIP1L) peptide
RPGRIP1L Reactivité: Humain, Chien Hôte: Synthetic BP, Imm
-
- Indications d'application
- RPGRIP1L Peptide is used for blocking the activity of RPGRIP1L antibody . The RPGRIP1L antibody ships at 0.5 mg/mL and the RPGRIP1L Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- RPGRIP1L peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
- Antigène
- RPGRIP1L (RPGRIP1-Like (RPGRIP1L))
- Synonymes
- si:ch1073-301i20.1 Peptide, mks5 Peptide, cors3 Peptide, jbts7 Peptide, nphp8 Peptide, CORS3 Peptide, FTM Peptide, JBTS7 Peptide, MKS5 Peptide, NPHP8 Peptide, 1700047E16Rik Peptide, 4931437C01 Peptide, Ftm Peptide, Nphp8 Peptide, RGD1311099 Peptide, RPGRIP1 like Peptide, RPGRIP1-like Peptide, Protein fantom Peptide, Rpgrip1-like Peptide, RPGRIP1L Peptide, rpgrip1l Peptide, mks-5 Peptide, Rpgrip1l Peptide
- ID gène
- 23322
- NCBI Accession
- NP_056087
- OMIM
- 118442834
- UniProt
- Q68CZ1
-
Vous êtes ici:
